5-membered heteroaryl carboxamide compounds for treatment of hbv
PH12022552815B1Active Publication Date: 2026-10-02ASSEMBLY BIOSCIENCES INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022552815
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-10-21
- Publication Date
- 2026-10-02
- Estimated Expiration
- 2042-10-21
Abstract
The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Need to check novelty before this filing date? Find Prior Art